Company / Interest Expense
Lexaria Bioscience Corp. Interest Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$43.2K
FY2024
5-year range
$43.2K / $43.2K
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed +1820% YoY in FY2024, a notable deviation from the 3-year average annual change of +549%.
Based on SEC 10-K filings.
$43,190 in FY2024.
Increased from $31,544 to $43,190 over the past 8 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $43.2K | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | $2.3K | -92.9% |
| FY2016 | $31.5K | -81.0% |
| FY2015 | $165.8K | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026